Kowdley, Kris V <br/><br/>
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir.  [electronic resource] 

 -  Liver international : official journal of the International Association for the Study of the Liver  11 2016 
 - 1611-1618 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article 
<br/><br/><label>ISSN: </label>1478-3231 
<br/><br/><label>Standard No.: </label>10.1111/liv.13165  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Carbamates<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Imidazoles--administration & dosage<br/>Liver Cirrhosis--blood<br/>Male<br/>Middle Aged<br/>Pyrrolidines<br/>RNA, Viral--blood<br/>Sofosbuvir--administration & dosage<br/>Sustained Virologic Response<br/>Time Factors<br/>United States<br/>Valine--analogs & derivatives<br/>Viral Load<br/>Young Adult